Congestión (sinusal)

5-HTP is the immediate precursor to serotonin, and reduced serotonergic activity is well-documented in women with PMS and PMDD. PET imaging studies confirm abnormal 5-HTP-derived serotonin activity in prefrontal cortices of women with premenstrual dysphoria. Systematic review evidence indicates 5-HTP is better than placebo for alleviating menstrual depression.

Calcium has the strongest evidence base among all supplements for PMS. A landmark RCT of 720 women showed 1,200 mg/day calcium carbonate produced a 48% overall reduction in PMS symptom scores versus placebo over three months. Multiple systematic reviews confirm calcium as the only natural product with consistently high-quality evidence for PMS.

Chamomile exhibits calming, sedative, and anti-inflammatory effects relevant to PMS, and was a component of the PMSoff supplement that significantly reduced PMS symptoms in a 2025 double-blind RCT. Traditional use for menstrual discomfort and anxiety is long-established across European and Middle Eastern herbal medicine.

Chaste Tree (Vitex agnus-castus) is approved by German health authorities for PMS and premenstrual mastodynia. Meta-analysis of three double-blind RCTs found women taking chaste tree were 2.57 times more likely to achieve PMS symptom remission versus placebo. Eight qualifying RCTs all showed positive results.

Curcumin, the principal bioactive of turmeric, has been evaluated in multiple RCTs for PMS and dysmenorrhea, with a 2025 systematic review of 10 RCTs finding that 6 reported significant PMS symptom improvement. Curcumin inhibits COX-2 and prostaglandin production and modulates inflammatory biomarkers and vitamin D status in PMS patients.

EPA-containing omega-3 supplementation has been studied for premenstrual syndrome (PMS), with evidence suggesting reductions in mood-related and physical symptoms via anti-inflammatory prostaglandin modulation. Krill oil (high in EPA+DHA) RCTs show reduced emotional symptoms and pain compared to placebo in PMS.

Evening primrose oil has been evaluated in multiple RCTs for PMS with mixed to negative findings. The 2009 Whelan systematic review found no evidence of benefit with evening primrose oil for PMS, while the DARE systematic review found mixed findings. It remains widely used traditionally despite inconclusive clinical trial evidence.

Multiple clinical trials have examined fennel for PMS symptom severity. Studies demonstrate statistically significant reductions in PMS severity scores with fennel extract vs. control groups. The effect appears consistent across studies including a randomized clinical trial in university students and a study comparing fennel with exercise.

Fenugreek has demonstrated clinical benefit for primary dysmenorrhea (painful menstruation)—a core PMS symptom—in a double-blind RCT showing significant pain reduction and improvement in associated systemic symptoms. Its anti-inflammatory and antispasmodic properties, along with phytoestrogenic action, are the proposed mechanisms.

A clinical trial of geranium aromatherapy massage demonstrated significant reduction in PMS symptoms. Geranium is proposed to stimulate the adrenal cortex and support hormonal balance. It has documented use for PMS-related emotional and physical symptoms in both clinical and traditional settings.

Ginger is listed among botanical supplements studied for PMS, and RCTs of ginger for dysmenorrhea (menstrual cramping, a core PMS symptom) show significant pain reduction. Multiple RCTs find ginger comparable to ibuprofen and mefenamic acid for dysmenorrhea pain, and it is listed among herbs used for PMS in authoritative botanical reviews.

Ginkgo biloba extract has been evaluated in RCTs for PMS, with studies finding reductions in congestive and mood-related PMS symptoms. A 2009 RCT using standardised EGb 761 extract administered from day 16 of the cycle through day 5 of the next cycle showed significant reductions in PMS symptom severity versus placebo.

The evidence for inositol in PMS/PMDD is mixed. A 2011 RCT (Carlomagno et al., Human Psychopharmacology) demonstrated efficacy of a new myo-inositol formulation in PMDD. However, an earlier 2002 small crossover RCT found no benefit, and a 2014 meta-analysis showed only a non-significant trend toward benefit for PMDD-related depressive symptoms. The phosphatidylinositol second messenger system provides a plausible mechanistic rationale.

Isoflavones as a class (including soy isoflavones) are phytoestrogens documented to show preliminary RCT evidence for PMS benefit in systematic reviews. They act as selective estrogen receptor modulators, modulating the hormonal environment of the menstrual cycle.

The Sampalis et al. (2003) double-blind RCT (n=70 women) found Neptune Krill Oil significantly improved both physical and emotional symptoms of PMS versus baseline, with improvements greater than the fish oil comparator. A 3-month pilot with 29 women using a krill oil-based formulation also showed significant reductions in PMS symptoms.

L-tryptophan is the dietary amino acid precursor to 5-HTP and ultimately serotonin, providing the upstream substrate for the serotonin pathway implicated in PMS. Tryptophan depletion studies worsen PMS mood symptoms, and L-tryptophan supplementation has been studied for PMDD-related depression and irritability.

Lavender aromatherapy has been evaluated in RCTs specifically for PMS and found to reduce psychological and physical symptoms. Lavender appeared in the PMSoff RCT combination supplement that significantly reduced PMS symptoms in a 2025 double-blind trial. Lavender's linalool and linalyl acetate have documented anxiolytic and analgesic properties.

Authoritative sources note that clinical trials of licorice-containing herbal combinations showed benefit in dysmenorrhea and PMS. Licorice isoflavones may inhibit serotonin reuptake, potentially addressing mood-related PMS symptoms. Phytoestrogenic compounds may modulate the hormonal fluctuations underlying PMS.

Magnesium deficiency has been implicated in PMS pathophysiology, with studies showing lower red blood cell magnesium in PMS patients. RCTs using magnesium pyrrolidone show preliminary benefit for premenstrual mood and fluid retention symptoms. A synergistic effect with vitamin B6 has been documented in a double-blind crossover RCT for anxiety-related PMS symptoms.

A controlled metabolic trial found that low dietary manganese was associated with increased mood and pain symptoms during the premenstrual phase. A PMC review identifies manganese among minerals potentially involved in PMS pathophysiology, though only one study with combined manganese/calcium exposure exists.

Omega-3 fatty acids (EPA/DHA) reduce production of pro-inflammatory prostaglandins that drive menstrual pain and PMS symptoms. A randomised double-blind trial in 184 women showed omega-3 supplementation reduced psychiatric and somatic PMS symptoms including depression, nervousness, anxiety, bloating, and headache. A systematic review with meta-analysis confirms anti-dysmenorrhea effects.

Phytoestrogens as a class—including soy isoflavones and red clover isoflavones—bind estrogen receptors and modulate the hormonal environment of PMS. They are listed among natural interventions studied for PMS management in systematic reviews and used in traditional and complementary medicine.

Clinical evidence supports Pycnogenol for relief of premenstrual symptoms including abdominal pain. A review of clinical pharmacology noted PYC relieves premenstrual symptoms including abdominal pain via spasmolytic action of phenolic acids. The menstrual cramp RCTs also enrolled women with PMS-type symptoms.

PMS is linked to the progesterone decline in the late luteal phase and to GABA-A receptor sensitivity to progesterone's metabolite allopregnanolone. The Cochrane-registered review of progesterone for PMS found insufficient evidence that oral or vaginal progesterone alone is superior to placebo, but the GABA-A neurosteroid mechanism linking progesterone fluctuations to PMS symptoms is well established.

A systematic review and meta-analysis of RCTs found Rosa damascena reduces menstruation-related headache, fatigue, anxiety, and bloating—core PMS symptoms. Multiple RCTs using aromatherapy and oral extract support this evidence. Traditional use of rose for PMS is well-documented in Persian medicine.

Saffron (Crocus sativus) has been evaluated in multiple RCTs for PMS and PMDD. Its bioactive compounds crocin and safranal inhibit reuptake of serotonin, dopamine, and norepinephrine. A double-blind RCT showed saffron was non-inferior to fluoxetine for PMDD; a systematic review confirmed positive effects on PMS mood and psychological symptoms.

Soy isoflavones have been included among products showing preliminary RCT evidence for PMS benefit in a 2009 systematic review. Isoflavones bind estrogen receptors and may modulate hormonal fluctuations contributing to PMS; one RCT found soy consumption reduced affective PMS symptoms versus placebo.

Soy isoflavones are the phytoestrogenic compounds responsible for soy's effects on PMS. Isoflavones genistein and daidzein bind estrogen receptors with SERM-like activity and may modulate the hormonal environment of PMS. RCT evidence is preliminary but present in systematic reviews.

Spirulina was a component of the PMSoff combination supplement that demonstrated significant PMS symptom reduction in a 2025 double-blind RCT. Spirulina has documented anti-inflammatory and antioxidant properties proposed to alleviate PMS-related symptoms. It is a nutrient-dense blue-green algae used in women's reproductive health contexts.

St. John's Wort (Hypericum perforatum) was tested in a double-blind, placebo-controlled crossover RCT in 36 women with mild PMS and was statistically superior to placebo for physical and behavioural PMS symptoms. Multiple systematic reviews include it among products with preliminary evidence for PMS benefit.

Valerian has sedative and GABAergic properties relevant to PMS-related insomnia and anxiety. An RCT evaluating valerian capsules for premenstrual mood and behavioural symptoms found a significant decrease in symptom severity. Valerian also appeared in the PMSoff combination RCT which demonstrated significant PMS benefit.

Vitamin B1 (thiamine) has been associated with improved mood and reduced anxiety in PMS, and appeared in the PMSoff combination supplement that showed significant PMS symptom reduction in a 2025 double-blind RCT. Observational data also link higher thiamine intake with lower PMS risk. Thiamine is also listed among nutritional supplements reported effective for dysmenorrhea.

Vitamin B6 is a cofactor in serotonin and dopamine synthesis, both relevant to PMS pathophysiology. A systematic review covering 25 studies found pooled evidence of benefit for vitamin B6 in PMS, though findings were mixed across individual trials. German Commission E and systematic reviews support its use, particularly for premenstrual depression.

Low vitamin D levels are associated with increased PMS risk and severity; PMS has been characterised as a calcium/vitamin D deficiency state that is unmasked during the luteal phase. RCTs of combined calcium and vitamin D show significant PMS symptom reduction, and a high-dose vitamin D3 trial showed reductions in PMS incidence.

Vitamin E has shown preliminary benefit for PMS in RCTs, particularly for mood and physical symptoms. The 2009 Whelan systematic review identified vitamin E among products with preliminary RCT evidence for PMS benefit. A combined vitamin D and E RCT (2024) showed significant PMS score reduction in vitamin D-deficient women.

Vitex agnus-castus (chasteberry) has been approved by German health authorities for PMS, breast tenderness, and menstrual irregularity. A 2020 meta-analysis of three double-blind RCTs found women taking VAC extracts were 2.57 times more likely to experience PMS symptom remission versus placebo. A 2017 systematic review identified 8 qualifying RCTs, all positive for VAC in PMS or PMDD.

A controlled study in 334 female students showed yarrow extract significantly reduced overall PMS symptom scores and pain severity versus placebo over three months. This constitutes direct clinical evidence for yarrow in premenstrual syndrome.

Agnuside is an iridoid glycoside and one of the marker compounds of Vitex agnus-castus (chasteberry). It contributes to the standardisation of chasteberry extracts used in PMS clinical trials and is considered a marker constituent of preparations with documented PMS efficacy.

Asparagus racemosus is traditionally used in Ayurvedic medicine to support female reproductive health, including for premenstrual complaints. Preclinical and limited clinical data support its hormonal modulating properties. No dedicated PMS RCT has been published.

Black cohosh has a documented traditional use for PMS and premenstrual mood and physical symptoms spanning Native American and 19th-century American practice. The NCCIH lists PMS as a promoted indication. Modern clinical trials targeting PMS specifically are very sparse, small, and inconclusive.

Borage oil has a documented traditional use for premenstrual syndrome, attributed to GLA's role in prostaglandin modulation, which may reduce breast tenderness, bloating, irritability, and cramping. Small studies suggest benefit but systematic reviews find insufficient high-quality evidence specific to borage oil.

Borage oil is widely used traditionally to relieve PMS symptoms including breast tenderness, cramping, mood changes, and fluid retention, attributed to GLA's ability to support prostaglandin E1 synthesis and modulate prolactin-related effects. Clinical evidence is primarily from EPO trials and not borage oil specifically; evidence for borage oil in PMS from RCTs is lacking.

In TCM, B. falcatum is a central herb for Liver Qi stagnation, a pattern that corresponds closely to PMS symptoms: irritability, mood swings, bloating, and cramping. It is the primary constituent of Jia Wei Xiao Yao San, historically used for premenstrual emotional disturbances. No isolated human clinical trials for PMS specifically with B. falcatum alone have been identified.

Casticin is a polymethoxylated flavone constituent of Vitex agnus-castus fruit, one of the bioactive compounds in chasteberry extracts used for PMS. It has documented anti-inflammatory and anti-proliferative properties in preclinical studies, contributing to the overall mechanism of action of Vitex preparations for PMS.

Cramp bark (Viburnum opulus) is used in traditional Western herbalism as a uterine antispasmodic and analgesic for menstrual cramps associated with PMS. Animal studies and human uterine tissue experiments suggest antispasmodic effects, but no PMS-specific placebo-controlled clinical trials have been performed.

Damiana is traditionally used in Latin American and European herbal medicine for premenstrual symptoms including irritability, nervous tension, and pelvic discomfort. Its nervine, antispasmodic, and mild phytoestrogenic actions provide biological plausibility. No clinical PMS trials exist.

PMS symptoms including mood changes, bloating, and breast tenderness are associated with luteal-phase estrogen-progesterone imbalance. DIM is used in integrative practice to reduce estrogen dominance thought to drive PMS. A double-blind RCT of DIM for cervical abnormalities included PMS as a monitored sub-study endpoint, providing limited formal data.

Wild yam is used in herbal medicine for PMS symptoms including cramping, mood changes, and hormonal discomfort, owing to its antispasmodic and mild phytoestrogenic properties. This is a well-documented traditional use. Clinical evidence is absent.

Dong quai (Angelica sinensis) has been used in Traditional Chinese Medicine for over 2,000 years as a primary women's tonic for menstrual irregularity, PMS, dysmenorrhea, and amenorrhea. It is considered 'female ginseng' in TCM. However, no placebo-controlled RCTs specifically for PMS have been conducted.

Gamma-linolenic acid (GLA) is the active omega-6 fatty acid in evening primrose oil proposed to address a GLA deficiency contributing to PMS via prostaglandin E1 deficiency. Clinical RCT evidence via evening primrose oil is mixed to negative in most rigorous trials, though GLA remains widely recommended in complementary medicine for PMS.

Kava is used in herbal medicine for premenstrual tension, irritability, and cramping, extending from its documented anxiolytic, antispasmodic, and muscle-relaxant properties. The clinical herbalist literature and traditional Pacific use support this application. No dedicated RCT exists for kava in PMS specifically.

Lemon balm (Melissa officinalis) is used in European traditional medicine for anxiety, insomnia, and nervous complaints associated with PMS. Its rosmarinic acid and flavonoids inhibit GABA transaminase, increasing GABA levels. Small clinical studies support anxiolytic and mood-improving effects relevant to PMS symptoms.

Maca has a well-documented traditional use for PMS among Andean peoples, listed in ethnobotanical records and pharmacobotanical monographs. Clinical research on maca for PMS as a distinct condition is absent, though related effects on hormonal balance and mood in perimenopausal women have some scientific support.

Marjoram has a traditional reputation for relieving PMS symptoms including abdominal cramps, headache, and mood disturbance, attributed to its antispasmodic, analgesic, and nervine properties. Clinical documentation for PMS specifically is limited to traditional and anecdotal records.

Mugwort is documented in traditional Chinese medicine for premenstrual syndrome, and moxibustion has been studied in a clinical context for reducing premenstrual cramping. Adams et al. (Chinese Medicine, 2012) specifically reviewed mugwort for PMS treatment. Human evidence is from moxibustion applications rather than oral supplementation.

Passionflower (Passiflora incarnata) is used traditionally in Western and South American herbalism for anxiety, insomnia, and nervous tension associated with PMS. Its GABA-enhancing and MAO-inhibiting properties provide mechanistic support for its anxiolytic use in PMS-related mood symptoms.

Paeonia lactiflora is a central ingredient in TCM formulas for premenstrual syndrome, addressing symptoms such as irritability, abdominal pain, breast distension, and mood changes. Its antispasmodic, anti-inflammatory, and estrogenic activities provide mechanistic plausibility, but isolated clinical trial evidence is absent.

Red clover (Trifolium pratense) contains isoflavones—formononetin, biochanin A, daidzein, and genistein—that act as phytoestrogens. It has been traditionally used for menopausal and menstrual complaints including PMS, with some small clinical studies on menopausal symptoms and preliminary evidence from the broader phytoestrogen literature.

Royal jelly has been traditionally used in several cultures to reduce PMS symptoms including mood swings and bloating, attributed to its phytoestrogenic activity. It is a popular supplement among women for this purpose, but dedicated controlled clinical trials specifically targeting PMS as a primary endpoint are lacking.

Skullcap is documented in traditional practice for PMS and nervous tension associated with the menstrual cycle. Encyclopedia.com lists PMS among its contemporary herbal uses. Cherokee women used it for menstrual health, and its anxiolytic and antispasmodic properties address core PMS symptoms.

Traditional and naturopathic herbalism documents squawvine for PMS, particularly the type accompanied by water retention, pelvic congestion, and irritability. Its combined diuretic, uterine-tonic, and mild nervine properties are cited as the basis. No clinical trials exist.

Suma is used in traditional South American herbal practice to relieve PMS symptoms, attributed to its phytosterol and ecdysteroid content that may modulate estrogen and progesterone levels. This use is documented but unconfirmed by human clinical trials.

The NIH LiverTox database lists premenstrual syndrome among the conditions for which tribulus has historically been used. Traditional Ayurvedic use for fluid retention and menstrual discomfort aligns with PMS symptoms. No RCT has directly studied tribulus for PMS.

Wild yam (Dioscorea villosa) has historically been used for menstrual cramps and PMS in North American and eclectic herbal medicine. Its steroidal saponin diosgenin is a pharmaceutical precursor to progesterone, though the human body cannot perform this conversion. It is more commonly recommended for PMS in traditional contexts than supported by clinical trials.

Wood betony is listed in traditional herbal practice specifically for pre-menstrual complaints, combining its nervine and antispasmodic properties. It is documented in folk and herbal literature for frayed nerves, tension, and mood disturbance associated with the premenstrual phase.